The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target

Lu Zhe Pan; Dae Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A. Gujar; Patrick W.K. Lee

doi:10.4161/cc.28128

The NAD⁺ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target

Lu Zhe Pan, Dae Gyun Ahn, Tanveer Sharif, Derek Clements, Shashi A. Gujar, Patrick W.K. Lee

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1041-1048
Number of pages	8
Journal	Cell Cycle
Volume	13
Issue number	6
DOIs	https://doi.org/10.4161/cc.28128
Publication status	Published - Mar 15 2014

ASJC Scopus Subject Areas

Molecular Biology
Cell Biology
Developmental Biology

Keywords

Apoptosis
NMNAT-2
p53

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/cc.28128

Cite this

Pan, L. Z., Ahn, D. G., Sharif, T., Clements, D., Gujar, S. A., & Lee, P. W. K. (2014). The NAD⁺ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target. Cell Cycle, 13(6), 1041-1048. https://doi.org/10.4161/cc.28128

@article{2b96725d85ca44ecbc702e8bab4bf1c2,

title = "The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target",

keywords = "Apoptosis, NMNAT-2, p53",

author = "Pan, {Lu Zhe} and Ahn, {Dae Gyun} and Tanveer Sharif and Derek Clements and Gujar, {Shashi A.} and Lee, {Patrick W.K.}",

note = "Funding Information: This work was supported by an operating grant from the Canadian Institute of Health Research (CIHR) to P.W.K.L., Cancer Research Training Program postdoctoral fellowships through the Beatrice Hunter Cancer Research Institute (D.A.), a Government of Canada Post-Doctoral Research Fellowship (D.A.), Canadian Institutes of Health Research (S.G.), and Nova Scotia Health Research Foundation (D.C.).",

year = "2014",

month = mar,

day = "15",

doi = "10.4161/cc.28128",

language = "English",

volume = "13",

pages = "1041--1048",

journal = "Cell Cycle",

issn = "1538-4101",

publisher = "Landes Bioscience",

number = "6",

}

TY - JOUR

T1 - The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target

AU - Pan, Lu Zhe

AU - Ahn, Dae Gyun

AU - Sharif, Tanveer

AU - Clements, Derek

AU - Gujar, Shashi A.

AU - Lee, Patrick W.K.

N1 - Funding Information: This work was supported by an operating grant from the Canadian Institute of Health Research (CIHR) to P.W.K.L., Cancer Research Training Program postdoctoral fellowships through the Beatrice Hunter Cancer Research Institute (D.A.), a Government of Canada Post-Doctoral Research Fellowship (D.A.), Canadian Institutes of Health Research (S.G.), and Nova Scotia Health Research Foundation (D.C.).

PY - 2014/3/15

Y1 - 2014/3/15

KW - Apoptosis

KW - NMNAT-2

KW - p53

UR - http://www.scopus.com/inward/record.url?scp=84897997735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897997735&partnerID=8YFLogxK

U2 - 10.4161/cc.28128

DO - 10.4161/cc.28128

M3 - Article

C2 - 24552824

AN - SCOPUS:84897997735

SN - 1538-4101

VL - 13

SP - 1041

EP - 1048

JO - Cell Cycle

JF - Cell Cycle

IS - 6

ER -